Admedus Limited Buy or Sell Recommendation

Macroaxis provides Admedus Limited buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding Admedus Limited positions. The advice algorithm takes into account all of Admedus Limited available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from Admedus Limited buy-and-hold prospective. Check also Admedus Limited Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with current analyst consensus

Time Horizon

Risk Tolerance

Execute Advice
Admedus Limited -- USA Stock  

USD 0.21  0.015  7.69%

Assuming 30 trading days horizon, and your above average risk tolerance our recommendation regarding Admedus Limited is 'Strong Sell'.
For the selected time horizon Admedus Limited has a risk adjusted performance of 0.0, jensen alpha of 0.0, total risk alpha of 0.0, sortino ratio of 0.0 and treynor ratio of 0.0
We provide buy or sell advice to complement the prevailing expert consensus on Admedus Limited. Our dynamic recommendation engine makes use of multi - dimensional algorithm to analyze the company potential to grow using all technical and fundamental data available at the time. To make sure Admedus Limited is not overpriced, please confirm all Admedus Limited fundamentals including its Debt to Equity, Total Asset and the relationship between Net Income and Earnings Per Share . As Admedus Limited appears to be a penny stock we also recommend to validate its Price to Book numbers.

Admedus Limited Greeks

Alpha over DOW
Beta against DOW=0.00
Overall volatility
Information ratio =0.00

Admedus Limited Volatility Alert

Admedus Limited exhibits very low volatility with skewness of 0.0 and kurtosis of 0.0. However, we advise investors to further study Admedus Limited technical indicators to make sure all market info is available and is reliable. Admedus Limited is a potential penny stock. Although Admedus Limited may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial stock hype. Please make sure you totally understand upside potential and downside risk of investing in Admedus Limited. We encourage investors to look for the signals such us email spams, message board hypes, claims of breakthroughs, volume upswings,sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on this equity instrument if you perfectly time your entry and exit. However, remember that penny stocks that has been the subject of an artificial hype usually unable to maintain its increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The one and only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.
 Better Than Average     
 Worse Than Average Compare Admedus Limited to competition
FundamentalsAdmedus LimitedPeer Average
Return On Equity(65.41) % (15.17) %
Return On Asset(35.80) % (15.64) %
Profit Margin(68.01) % (5.50) %
Operating Margin(83.35) % (10.91) %
Current Valuation50.82 M152.14 B
Shares Outstanding254.8 M1.43 B
Price to Earning3.20 times40.69 times
Price to Book4.88 times14.44 times
Price to Sales3.58 times17.81 times
Revenue16.49 M9.85 B
Gross Profit10.29 M21.75 B
EBITDA(12.4 M)1.41 B
Net Income(11.21 M)517.71 M
Cash and Equivalents6.36 M3.89 B
Cash per Share0.03 times5.17 times
Total Debt3.67 M7.36 B
Debt to Equity31.90 % 0.72 %
Current Ratio1.58 times3.30 times
Book Value Per Share0.04 times13.64 times
Cash Flow from Operations(7.48 M)1.25 B
Earnings Per Share0.04 times2.30 times
Number of Employees1210.67 K
Market Capitalization58.96 M29.78 B
Total Asset27 M126.86 B
Retained Earnings(69 M)38.24 B
Working Capital13 M3.58 B
Current Asset17 M36.8 B
Current Liabilities4 M33.34 B
Z Score6.8708.73
Not Rated
Coefficient Of Variation0.0
Maximum Drawdown0.0
Potential Upside0.0